Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Intima-Medial Thickness Guidance of Primary Prevention in Relatives of Patients With Early onSet Atherosclerosis: The IMPRESS Study- A Multi-centre, Randomised Controlled Trial

NCT01330602 is registered in ClinicalTrials.gov with National University Hospital, Singapore as lead sponsor.

NCT NCT01330602
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01330602 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Intima-Medial Thickness Guidance of Primary Prevention in Relatives of Patients With Early onSet Atherosclerosis: The IMPRESS Study- A Multi-centre, Randomised Controlled Trial
Lead sponsor
National University Hospital, Singapore
Phase
Not applicable
Overall status
Unknown status
Start date
May 31, 2010
Completion date
December 31, 2013
Enrollment
1,310 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

atherosclerotic cardiovascular disease, cardiovascular disease